Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial

Publication

Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial

Journal Paper/Review - Jan 11, 2021

Rassouli Frank, Tamm M, Sievi N A, Tschirren U, Widmer Sandra, Kähler C, Brack T, Thurnheer R, Stolz D, Kohler M, Baty Florent, Germann A, Brutsche Martin

Citation

Rassouli F, Tamm M, Sievi N, Tschirren U, Widmer S, Kähler C, Brack T, Thurnheer R, Stolz D, Kohler M, Baty F, Germann A, Brutsche M. Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial. J Intern Med 2021; 289:404-410.

Type

Journal Paper/Review (English)

Journal

J Intern Med 2021; 289

Publication Date

Jan 11, 2021

Issn Electronic

1365-2796

Pages

404-410

Brief description/objective

BACKGROUND
We showed excellent adherence and satisfaction with our telehealth care (TC) approach for COPD. Here, the results of a consecutive randomized controlled trial are presented.

METHODS
Patients were randomly assigned to TC or standard care (SC). During TC, patients answered six daily questions online, and focused on the early recognition of exacerbations, in addition to SC.

RESULTS
The mean increase in COPD assessment test (CAT) was 1.8 vs. 3.6 points/year in the TC and SC groups, respectively (P = 0.0015). Satisfaction with care (VAS) at baseline was 8.2; at the end of SC, 8.5 (P = 0.062); and after TC, 8.8 (P < 0.001). We detected significantly more moderate exacerbations during TC.

CONCLUSION
Whilst receiving TC, the slope of the CAT increase - an indicator of the naturally progressive course of COPD - was reduced by 50%. Satisfaction with care increased with TC. The higher number of detected moderate exacerbations probably indicates a higher diagnostic sensitivity than without TC.